Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is commonly employed, despite the low activity, considering the lack of other effective systemic treatments. In this study, the prognostic and predictive role of soluble immune checkpoints and inflammatory cytokines/chemoki...

Full description

Bibliographic Details
Main Authors: Ernesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, Anna Acampora, Monica Maria Pagliara, Maria Grazia Sammarco, Maurizio Simmaco, Luana Lionetto, Andrea Botticelli, Emilio Bria, Paolo Marchetti, Maria Antonietta Blasi, Giampaolo Tortora, Giovanni Schinzari, Marianna Nuti
Format: Article
Language:English
Published: Taylor & Francis Group 2022-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
uveal melanoma
pd-1
soluble checkpoint
immunotherapy
Online Access:http://dx.doi.org/10.1080/21645515.2022.2034377

Internet

http://dx.doi.org/10.1080/21645515.2022.2034377

Similar Items